It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
DNA methylation is a key epigenetic modification to regulate gene expression in mammalian cells. Abnormal DNA methylation in gene promoters is common across human cancer types. DNMT3B is the main de novo methyltransferase enhanced in several primary tumors. How de novo methylation is established in genes related to cancer is poorly understood. CpG islands (CGIs), common sequences, and transcription factors (TFs) that interact with DNMT3B have been associated with abnormal de novo methylation. We initially identified cis elements associated with DNA methylation to investigate the contribution of DNMT3B overexpression to the deregulation of its possible target genes in an epithelial cell model. In a set of downregulated genes (n = 146) from HaCaT cells with DNMT3B overexpression, we found CGI, common sequences, and TFs Binding Sites that interact with DNMT3B (we called them P-down-3B). PPL1, VAV3, IRF1, and BRAF are P-down-3B genes that are downregulated and increased their methylation in DNMT3B presence. Together these findings suggest that methylated promoters aberrantly have some cis elements that could conduce de novo methylation by DNMT3B.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Universidad Autónoma de Guerrero, Laboratorio de Epigenética del Cáncer, Facultad de Ciencias Químico Biológicas, Chilpancingo, Mexico (GRID:grid.412856.c) (ISNI:0000 0001 0699 2934)
2 Universidad Nacional Autónoma de México, Departamento de Genética Molecular, Instituto de Fisiología Celular, Ciudad de México, Mexico (GRID:grid.9486.3) (ISNI:0000 0001 2159 0001)
3 Universidad Autónoma de Guerrero, Av. Lázaro Cárdenas S/N Col. Haciendita, Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Chilpancingo, Mexico (GRID:grid.412856.c) (ISNI:0000 0001 0699 2934)
4 Universidad Autónoma de Guerrero, Laboratorio de Citopatología e Inmunohistoquímica, Facultad de Ciencias Químico Biológicas, Chilpancingo, Mexico (GRID:grid.412856.c) (ISNI:0000 0001 0699 2934)
5 Universidad Autónoma de Guerrero, Laboratorio de Virus y Cáncer, Facultad de Ciencias Químico Biológicas, Chilpancingo, Mexico (GRID:grid.412856.c) (ISNI:0000 0001 0699 2934)